19 May 2013
Keywords: nice, oks, novartis, glivec, patients, all, stages
Article | 19 August 2002
The National Health Service in England and Wales should make Novartis'Glivec (imatinib) available to patients with chronic myeloid leukemia at
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 August 2002
17 May 2013
© 2013 thepharmaletter.com